These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6978846)

  • 21. Differential antibody production of adherent and nonadherent spleen cells transferred to irradiated and cyclophosphamide-treated recipient mice.
    Albright JF; Deitchman JW; Hassell SA; Ozato K
    J Reticuloendothel Soc; 1975 Apr; 17(4):195-209. PubMed ID: 1097674
    [No Abstract]   [Full Text] [Related]  

  • 22. Augmentation of antitumor cytotoxicity of MOPC-315 tumor bearer spleen cells by depletion of dinitrophenol-adherent cells prior to in vitro immunization.
    Mokyr MB; Hengst JC; Przepiorka D; Dray S
    Cancer Res; 1979 Oct; 39(10):3928-34. PubMed ID: 157800
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of neonatal idiotype suppression. II. Alterations in the T cell compartment suppress the maturation of B cell precursors.
    Fung J; Köhler H
    J Immunol; 1980 Dec; 125(6):2489-95. PubMed ID: 6448897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas.
    Padarathsingh ML; McCoy JL; Dean JH; Lewis DD; Northing JW; Law LW
    J Natl Cancer Inst; 1977 Jun; 58(6):1701-7. PubMed ID: 301196
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of interferon on antibody synthesis in vitro.
    Gisler RH; Lindahl P; Gresser I
    J Immunol; 1974 Aug; 113(2):438-44. PubMed ID: 4602660
    [No Abstract]   [Full Text] [Related]  

  • 27. [T x B hybrid clones capable of inhibiting the development of leukosis in vivo].
    Petrov RV; Sidorovich IG; Ignat'eva GA; Fuks BB
    Dokl Akad Nauk SSSR; 1983; 269(2):504-8. PubMed ID: 6602039
    [No Abstract]   [Full Text] [Related]  

  • 28. Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation.
    Mokyr MB; Braun DP; Dray S
    Cancer Res; 1979 Mar; 39(3):785-92. PubMed ID: 427766
    [No Abstract]   [Full Text] [Related]  

  • 29. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.
    Yamashita U; Hamaoka T
    J Immunol; 1979 Dec; 123(6):2637-43. PubMed ID: 315427
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice.
    Chia E; Festenstein H
    Eur J Immunol; 1973 Aug; 3(8):483-7. PubMed ID: 4543175
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional maturation of neonatal spleen cells.
    Bösing-Schneider R
    Immunology; 1979 Mar; 36(3):527-32. PubMed ID: 312262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of adherent cells. I. Distribution and ontogeny of A cells participating in the response to sheep erythrocytes in vitro.
    Landahl CA
    Eur J Immunol; 1976 Feb; 6(2):130-4. PubMed ID: 964296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.
    Platica M; Bojko C; Steiner G; Hollander VP
    Cancer Res; 1980 Jul; 40(7):2229-33. PubMed ID: 6248200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogen structure and cell selection. I. Cellular requirements for the in vitro response to moderately haptenated forms of the solid-phase immunogen DNP-O-Bio-Gel-P.
    Trump GN
    J Immunol; 1976 Aug; 117(2):419-22. PubMed ID: 1084896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonspecific activation of murine lymphocytes. V. Role of cellular collaboration between T and B lymphocytes in the proliferative and polyclonal response to 2-mercaptoethanol.
    Goodman MG; Weigle WO
    J Immunol; 1979 Apr; 122(4):1433-9. PubMed ID: 312842
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of cigarette tobacco smoke products on the immune response. The cellular basis of immunosuppression by a water-soluble condensate of tobacco smoke.
    Jacob CV; Stelzer GT; Wallace JH
    Immunology; 1980 Aug; 40(4):621-7. PubMed ID: 7000690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of depressed general immunocompetence and anti-tumor immunity in plasmacytoma-bearing mice demonstrating suppressor cell activity.
    Padarathsingh ML; Dean JH; Jerrells TR; Keys L; McCoy JL; Law LW
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(6):589-95. PubMed ID: 6452210
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune suppression in vivo with antigen-modified syngeneic cells. IV. Requirement for Ia+ adherent cells for induction.
    Sherr DH; Heghinian KM; Benacerraf B; Dorf ME
    J Immunol; 1980 Mar; 124(3):1389-95. PubMed ID: 6153681
    [No Abstract]   [Full Text] [Related]  

  • 39. Release of immunosuppressive factor(s) by MOPC-315 murine plasmacytoma cells: a possible mechanism of defence.
    Bomstein Y; Ophir R; Harshemes H; Ben-Efraim S
    Anticancer Res; 1993; 13(6A):2125-9. PubMed ID: 8297124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of intracisternal A-particles and of RNA molecules in plasmacytoma-associated immunodeficiency.
    Katzmann J; Bhoopalam N; Heller P; Hwang LT; Ostro M; Lavelle D; Giacomoni D
    Cancer Res; 1978 Aug; 38(8):2555-61. PubMed ID: 307429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.